Search The Medical Knowledge Base

Drug Details

PAVACOL-D

• Drug Class Description
  Opiates (opioids / cough suppressants).
• Generic Name
  Ingelheim Pholcodine
• Presentation
  Liquid for oral administration
• Description
  Dark brown liquid containing 5 mg of Pholcodine BP in each 5 ml
• Indications
  For the symptomatic treatment of dry troublesome coughs
• Adult Dosage
  

  One or two 5 ml spoonfuls as required. The dose may be increased to three 5 ml spoonfuls if necessary. No more than 60 ml should be taken in 24 hours.

• Child Dosage
  

  From 6 to 12 years: one 5 ml spoon four to five times daily. No more than 25ml should be taken in 24 hours.

  Do not give to children under 6 years of age.

  Pavacol-D may be diluted with sorbitol solution BPC.

  No specific information on the use of this product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.

• Contra Indications
  

  Hypersensitivity to any of the ingredients, liver disease or ventilatory failure.

• Special Precautions
  

  Cough suppressants may cause sputum retention and this may be harmful in patients with chronic bronchitis and bronchiectasis. If symptoms persist longer than 5 days a physician should be consulted.

  As pholcodine is a sedative, caution is needed in those patients who have airway disease e.g. asthma, chronic obstructive pulmonary disease (COPD), ventilatory insufficiency, as respiratory depression may occur. Caution is also needed in patients with kidney disease or a history of drug abuse.

• Interactions
  Alcohol or other CNS depressants.
• Adverse Drug Reactions
  

  Nausea, sputum retention and constipation occur occasionally after taking pholcodine. Immune system disorder such as hypersensitivity reactions and anaphylaxis have been reported.